Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with CYTK: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
CYTK
Cytokinetics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
CYTK
Cytokinetics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
CYTK
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±8.4%
▼
−12.66%
×1.51
Q2 FY26
±7.7%
▼
−5.67%
×0.74
= implied
LLY realized, solid
CYTK realized, hatched
One scale, both sides: full bar = 13%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±10.5%
▼
−2.92%
×0.28
Feb 25 '26
±10.0%
▼
−10.29%
×1.03
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
CYTK
Cytokinetics Inc
Change
53.83
▼
−3.09%
· post 54.39
Closed
Nov 6 '26
Mkt cap
$7.5B
Revenue
$48M
Q3 FY26
Revenue
$88M
FY25
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
CYTK
Cytokinetics Inc
1,360.90
▼
−0.28%
post 1,358.90
Price
53.83
▼
−3.09%
post 54.39
$1.2T
Mkt cap
$7.5B
Q3 FY26
$24.4B
Revenue
$48M
Q3 FY26
FY25
$65.2B
Revenue
$88M
FY25
Change
Change
LLY
1,360.90
▼
−0.28%
vs
CYTK
53.83
▼
−3.09%
Closed
Nov 6 '26